Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Protagonist Therapeutics Inc sell StockNews.com

Start price
€41.80
31.05.25 / 50%
Target price
-
31.05.26
Performance (%)
93.78%
End price
€81.00
01.06.26
Summary
This prediction ended on 01.06.26 with a price of €81.00. The SELL prediction by StockNews_com for Protagonist Therapeutics Inc was trending in the completely wrong direction and closed with a performance of 93.78%. StockNews_com has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Protagonist Therapeutics Inc -1.681% -1.681% 144.770%
iShares Core DAX® 1,01 % 2,70 % 4,36 %
iShares Nasdaq 100 -6,47 % -8,77 % 18,00 %
iShares Nikkei 225® -6,52 % -12,58 % 40,91 %
iShares S&P 500 -2,72 % -1,75 % 16,97 %

Comments by StockNews_com for this prediction

In the thread Protagonist Therapeutics Inc diskutieren

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat

In the thread Trading Protagonist Therapeutics Inc
Prediction Sell
Perf. (%) 93.78%
Target price
Change
Ends at 31.05.26

Die von StockNews_com gewählte maximale Laufzeit wurde überschritten

Stopped prediction by StockNews_com for Protagonist Therapeutics Inc

Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€117.00
18.10.23
-
18.10.24
-
19.10.24

Protagonist Therapeutics Inc

Start price
Target price
Perf. (%)
€117.00
30.09.23
-
30.09.24
-
01.10.24